France Funded Two Cancer Drugs the Same Week. One Was Rated Therapeutic Progress, One Was Not.
Listing is granted by indication, not by licence. Columvi is funded for one situation and refused for the rest of its authorisation.
Henlius
Listing is granted by indication, not by licence. Columvi is funded for one situation and refused for the rest of its authorisation.